CRS 2025 (v25.0)

CRS VERSION 25.0

CRS Version 25.0 is expected to be released in April 2025.

View the CRS 2025 (v25.0) National GPRA/GPRAMA Report Performance Measure List and Definitions [PDF - 697 KB]

View the CRS 2025 (v25.0) National GPRA Developmental Report Performance Measure List and Definitions [PDF - 800 KB]

Key enhancements included in CRS Version 25.0 are shown below.

• Logic Changes to National GPRA/GPRAMA Report Measures
• GPRA Developmental Measures:
• Updated codes and/or logic in the following measures: Statin Therapy to Reduce Cardiovascular Disease Risk in Patients with Diabetes; Adult Immunizations.
• Statin Therapy to Reduce Cardiovascular Disease Risk in Patients with Diabetes: Active diagnosis of ASCVD updated to any time prior to the end of the report period.
• Adult Immunizations: Added PCV21 to Pneumococcal definition.
• Childhood Immunizations: (1) Added PCV21 to Pneumococcal definition. (2) Added LOINC codes 104170-6, 104132-6 to BGP HPV LOINC CODES. (3) Added LOINC code 104132-6 to BGP HPV PRIMARY LOINC CODES.
• Intimate Partner (Domestic) Violence Screening: Updated code and/or logic to IPV/DV Related Diagnosis definition.
• Statin Therapy for the Prevention and Treatment of Cardiovascular Disease: Active diagnosis of ASCVD updated to any time prior to the end of the report period.

CRS 2025 DOCUMENTATION

CRS 2025 (v25.0) National GPRA/GPRAMA Report Performance Measure List and Definitions [PDF - 697 KB]

CRS 2025 (v25.0) National GPRA Developmental Report Performance Measure List and Definitions [PDF - 800 KB]

CRS 2025 (v25.0) Selected Measures Report Performance Measure List and Definitions [PDF - 1.1 MB]

CRS 2025 (v25.0) Elder Care Report Performance Measure List and Definitions [PDF - 470 KB]

CRS 2025 (v25.0) IPC Measures Report Performance Measure List and Definitions [PDF - 550 KB]